Reduced activation of the BMPR2 pathway has been observed in both hereditary PAH (with >80% of these patients carrying identified mutations in the BMPR2 gene) and non-hereditary forms of PAH [68]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.